IQuity Labs, a Nashville, TN-basedbiotechnology company specializing in diagnostic tests for autoimmune disease and related conditions, secured $2m in seed funding.
The backers were not disclosed.
The company will use the funds to launch its test panels.
Led by Chase Spurlock, PhD, CEO, and Julia B. Polk, COO and CFO, IQuity Labs is developing rapid diagnostic tests that confirm the presence or absence of autoimmune disease and related conditions at the onset of symptoms. The test was developed within Vanderbilt University Medical Center’s research community and has also received peer-reviewed grant funding from the National Institutes of Health.
The company plans to launch its first test for multiple sclerosis in the second quarter of 2016, with panels for additional autoimmune diseases (in the fields of gastroenterology and rheumatology) expected to be released throughout the second half of the year.